Stay updated on Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial

Sign up to get notified when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Footer revision text updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T17:54:07.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the site-wide government funding/operating status notice from the page, which does not affect the study record or its data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T17:49:43.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A new version of the study record was posted, updating recruitment status and study status (and related details) in the record history.
    Difference
    0.1%
    Check dated 2025-11-03T12:30:50.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    13%
    Check dated 2025-10-05T16:40:50.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T09:57:13.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The Back to Top element was removed, with no other substantive content changes observed.
    Difference
    0.8%
    Check dated 2025-09-14T00:13:36.000Z thumbnail image

Stay in the know with updates to Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.